Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-24 @ 7:19 PM
NCT ID:
NCT05587803
Eligibility Criteria:
Inclusion Criteria:
* Sedated patients hospitalized in ICU of the University Hospital of Brussels
* Patients who are monitored with the SEDline/Masimo monitor
* Patients who receive Remifentanil at a maximum concentration of 0,2 μg/kg/min and propofol with a concentration between 0,5-4,0 mg/kg/h
* Age above 18 years
Exclusion Criteria:
* Patients with facial trauma
* Pregnant patients
* Patients who received muscle re-laxants
* Patients in prone position
* Lack of informed consent from the family
* Patients who are hemodynamically unstable
* Patients with neurotrauma or every other neurologic disorder
* Patients post neurosurgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05587803
Study Brief:
Protocol Section:
NCT05587803